Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
107,228,372
-
Number of holders
-
124
-
Total 13F shares, excl. options
-
55,227,508
-
Shares change
-
+817,936
-
Total reported value, excl. options
-
$1,262,686,245
-
Value change
-
+$19,995,693
-
Number of buys
-
58
-
Number of sells
-
-55
-
Price
-
$22.86
Significant Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) as of Q3 2020
139 filings reported holding RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share as of Q3 2020.
ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) has 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55,227,508 shares
of 107,228,372 outstanding shares and own 52% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (16,812,491 shares), TANG CAPITAL MANAGEMENT LLC (2,965,485 shares), BlackRock Inc. (2,875,195 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,359,266 shares), PERCEPTIVE ADVISORS LLC (2,189,010 shares), VANGUARD GROUP INC (1,918,005 shares), WELLINGTON MANAGEMENT GROUP LLP (1,681,605 shares), STATE STREET CORP (1,633,055 shares), LORD, ABBETT & CO. LLC (1,591,395 shares), and EVENTIDE ASSET MANAGEMENT, LLC (1,550,000 shares).
This table shows the top 124 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.